东诚药业(002675)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002675 东诚药业

已收盘 05-16 15:00:00

{"stockData":{"symbol":"002675","market":"SZ","secType":"STK","nameCN":"东诚药业","latestPrice":13.19,"timestamp":1715843013000,"preClose":13.29,"halted":0,"volume":9222131,"delay":0,"floatShares":766000000,"shares":825000000,"eps":0.2716,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.1,"latestTime":"05-16 15:00:00","open":13.25,"high":13.39,"low":13.11,"amount":122000000,"amplitude":0.0211,"askPrice":13.19,"askSize":22,"bidPrice":13.18,"bidSize":26,"shortable":0,"etf":0,"ttmEps":0.2716,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715909400000},"adr":0,"adjPreClose":13.29,"symbolType":"stock","openAndCloseTimeList":[[1715823000000,1715830200000],[1715835600000,1715842800000]],"highLimit":14.62,"lowLimit":11.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":824595705,"pbRate":2.19,"roa":"--","roe":"1.34%","epsLYR":0.2543,"committee":0.163731,"marketValue":10876000000,"floatMarketCap":10100000000,"peRate":48.564063,"changeRate":-0.0075,"turnoverRate":0.012,"status":1},"requestUrl":"/m/hq/s/002675","defaultTab":"news","newsList":[{"id":"2435187826","title":"东诚药业（002675）5月15日主力资金净卖出314.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435187826","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435187826?lang=zh_cn&edition=full","pubTime":"2024-05-16 09:22","pubTimestamp":1715822525,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月15日收盘，东诚药业报收于13.29元，下跌2.71%，换手率1.09%，成交量8.32万手，成交额1.11亿元。近5日资金流向一览见下表：东诚药业融资融券信息显示，融资方面，当日融资买入1127.77万元，融资偿还695.49万元，融资净买入432.28万元，连续3日净买入累计1088.82万元。东诚药业主营业务：肝素钠原料药、硫酸软骨素的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051600010219.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435680012","title":"东诚药业(002675.SZ)下属公司河北安迪科被认定为河北省专精特新中小企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2435680012","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435680012?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:20","pubTimestamp":1715768449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东诚药业(002675.SZ)公告，公司下属公司河北安迪科正电子技术有限公司(简称“河北安迪科”)被认定为河北省“专精特新”中小企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121578.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435021599","title":"东诚药业：公司依托原料药的产业资源优势，探索利用合成生物学布局相关产品领域，助力公司的发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2435021599","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435021599?lang=zh_cn&edition=full","pubTime":"2024-05-14 19:02","pubTimestamp":1715684561,"startTime":"0","endTime":"0","summary":"证券之星消息，东诚药业05月14日在投资者关系平台上答复投资者关心的问题。作为今后东诚药业合成生物主生产基地，请介绍详细情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400028193.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435326867","title":"东诚药业：公司的管线及进展情况，请您查阅并参考2023年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2435326867","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435326867?lang=zh_cn&edition=full","pubTime":"2024-05-13 19:03","pubTimestamp":1715598180,"startTime":"0","endTime":"0","summary":"东诚药业董秘：您好，公司的管线及进展情况，请您查阅并参考2023年度报告，感谢您的关注！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300020931.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433729061","title":"东诚药业：5月8日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729061","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433729061?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:38","pubTimestamp":1715175512,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年5月8日东诚药业发布公告称公司于2024年5月8日召开业绩说明会。2023年度扣非净利润同比2022年下滑，主要是由于公司加大研发投入及原料药业务受国际市场影响销量及价格有所下滑所致。宇研为公司参股公司，公司持有其10%股权。原料药与制剂方面，公司不断夯实特色原料药业务，大力发展制剂业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800039862.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433424553","title":"东诚药业(002675.SZ)下属公司LNC关于18F-LNC1007注射液临床试验申请获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2433424553","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433424553?lang=zh_cn&edition=full","pubTime":"2024-05-06 19:53","pubTimestamp":1714996381,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东诚药业(002675.SZ)发布公告，2024年5月2日，公司下属公司LNC PHARMA PTE.LTD.(简称“LNC”)收到美国食品药品监督管理局(简称“FDA”)核准签发的关于18F-LNC1007注射液的药品临床试验批准通知书，将于近期在澳大利亚开展I期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117784.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432557907","title":"百亿私募一季度持仓浮出水面：冯柳、邓晓峰、杨东最新买了这些股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432557907","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2432557907?lang=zh_cn&edition=full","pubTime":"2024-05-01 07:58","pubTimestamp":1714521480,"startTime":"0","endTime":"0","summary":"　　随着上市公司一季报披露结束，百亿私募的最新持仓浮出水面。　　私募排排网不完全统计数据显示，截至4月30日，共有35只百亿私募出现在244家上市公司前十大流通股东名单，合计持股市值716.44亿元。其中，百亿私募一季度增持上市公司32家，新进上市公司54家，减持上市公司47家，另有111家上市公司持股数量不变。　　从集中度方面来看，共有9只个股被超过14只私募产品持有。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-05-01/doc-inatsrka7950033.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-05-01/doc-inatsrka7950033.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431266380","title":"平安证券：给予东诚药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431266380","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431266380?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:52","pubTimestamp":1714359121,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,韩盟盟近期对东诚药业进行研究并发布了研究报告《肝素原料药致业绩短期承压，2024年迎来核药管线落地期》，本报告对东诚药业给出买入评级，当前股价为13.71元。　　核医学全产业链优势明显，短期业绩压力不改长期发展潜力，维持“强烈推荐”评级。2）肝素原料药价格不及预期风险：肝素原料药触底反弹节奏可能存在不及预期可能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900007404.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431107360","title":"东诚药业(002675.SZ)子公司¹⁷⁷Lu-LNC1008注射液临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2431107360","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431107360?lang=zh_cn&edition=full","pubTime":"2024-04-29 08:18","pubTimestamp":1714349933,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东诚药业(002675.SZ)发布公告，2024年4月26日，公司控股子公司烟台蓝纳成生物技术有限公司收到中国国家药品监督管理局核准签发的关于¹⁷⁷Lu-LNC1008注射液的药物临床试验批准通知书，将于近期开展临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113833.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430202658","title":"东诚药业(002675.SZ)发布一季度业绩，净利润6432.75万元，增长28.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430202658","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430202658?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:38","pubTimestamp":1714145930,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东诚药业(002675.SZ)发布2024年一季度报告，报告期内实现营业收入6.47亿元，同比下降23.90%。归属于上市公司股东的净利润6432.75万元，同比增长28.38%。归属于上市公司股东的扣除非经常性损益的净利润5485万元，同比增长29.40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112754.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430279920","title":"东诚药业最新公告：一季度净利润6432.75万元 同比增长28.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430279920","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430279920?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:39","pubTimestamp":1714135182,"startTime":"0","endTime":"0","summary":"东诚药业公布2024年一季度报告，报告期营业收入6.47亿元，同比下降23.90%；归属于上市公司股东的净利润6432.75万元，同比增长28.38%；归属于上市公司股东的扣除非经常性损益的净利润5484.997万元，同比增长29.40%；基本每股收益0.0780元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600052531.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420237265","title":"东诚药业旗下米度生物融资近4亿聚焦创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2420237265","media":"证券时报","top":-1,"share":"https://www.laohu8.com/m/news/2420237265?lang=zh_cn&edition=full","pubTime":"2024-03-19 07:03","pubTimestamp":1710802980,"startTime":"0","endTime":"0","summary":"　　3月18日，东诚药业公告，同意下属子公司米度（烟台）生物技术有限公司增资扩股，由国投招商领投，国投聚力、山东地方产业基金等跟投，合计融资近4亿元。　　在非核药领域，米度生物作为分子影像CRO，在小分子、多肽、抗体、多糖、细胞治疗等创新品类上的临床前分子标记能力卓越，具有良好的放射性示踪剂生产和影像分析能力，并获得全球知名药企的认可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-03-19/doc-inanvcia9687900.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-03-19/doc-inanvcia9687900.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385933958","title":"东诚药业(002675.SZ)：氟思睿肽注射液III期临床试验获得伦理委员会批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2385933958","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2385933958?lang=zh_cn&edition=full","pubTime":"2023-11-24 18:15","pubTimestamp":1700820900,"startTime":"0","endTime":"0","summary":"来源：格隆汇格隆汇11月24日丨东诚药业(002675.SZ)公布，近日，烟台东诚药业集团股份有限公司控股子公司烟台蓝纳成生物技术有限公司(简称“蓝纳成”)收到北京医院伦理委员会出具的关于氟[18F]思睿肽注射液III期临床试验的伦理审查意见，氟[18F]思睿肽注射液可正式开展III期临床试验。\n\n现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-24/doc-imzvtiis4528972.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-24/doc-imzvtiis4528972.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-05-25","address":"山东省烟台市福山区经济技术开发区长白山路7号","stockEarnings":[{"period":"1week","weight":-0.0384},{"period":"1month","weight":0.0176},{"period":"3month","weight":-0.1092},{"period":"6month","weight":-0.2722},{"period":"1year","weight":-0.1203},{"period":"ytd","weight":-0.275}],"companyName":"烟台东诚药业集团股份有限公司","boardCode":"AI0027","perCapita":"32360股","boardName":"医药制造业","registeredCapital":"82459万元","compareEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":0.0204},{"period":"3month","weight":0.0886},{"period":"6month","weight":0.0215},{"period":"1year","weight":-0.052},{"period":"ytd","weight":0.0487}],"survey":"　　烟台东诚药业集团股份有限公司的主营业务为生化原料药、中西药制剂、放射性核素药物的研发、生产、销售。主要产品为原料药相关产品、制剂产品、核药产品。公司是国内最大的生化原料药供应商之一。公司肝素类药物关键制备技术及质控体系创新与应用，获得中国商业联合会科学技术奖一等奖。","serverTime":1715843249523,"listedPrice":26,"stockholders":"23663人(较上一季度增加17.36%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东诚药业(002675)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东诚药业(002675)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东诚药业,002675,东诚药业股票,东诚药业股票老虎,东诚药业股票老虎国际,东诚药业行情,东诚药业股票行情,东诚药业股价,东诚药业股市,东诚药业股票价格,东诚药业股票交易,东诚药业股票购买,东诚药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东诚药业(002675)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东诚药业(002675)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}